(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Epizyme (EPZM) said Chief Medical and Development Officer Shefali Agarwal has resigned to "pursue other business opportunities." Following her...
| Address | 400 Technology Square Cambridge, Massachusetts 02139 |
| Phone | +1.617.229.5872 |
| Number of Employees | 124 |
| Recent SEC Filing | 05/24/2022 8-K |
| President, Chief Executive Officer, CFO & Director | Grant C. Bogle |
| Chief Operating Officer | Jerald Korn |
| Chief Scientific Officer & Executive VP | Jeffery L. Kutok |
| Secretary, Senior Vice President & General Counsel | John F. Weidenbruch |
| Price Open | $0.48 |
| Previous Close | $0.48 |
| 52 Week Range | $0.44 - 9.86 |
| Market Capitalization | $74.7 M |
| Shares Outstanding | 164.9 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/08/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$2.20 |
| Beta vs. S&P 500 | N/A |
| Revenue | $21.7 M |
| Net Profit Margin | -614.08% |
| Return on Equity | -1,287.29% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
